Afhalen na 1 uur in een winkel met voorraad
Gratis thuislevering in België vanaf € 30
Ruim aanbod met 7 miljoen producten

Afhalen na 1 uur in een winkel met voorraad
Gratis thuislevering in België vanaf € 30
Ruim aanbod met 7 miljoen producten

Winkels

Verlanglijstje

Winkels

Verlanglijstje

Zoeken

Volg ons op

140 winkels

Wist je dat er in Vlaanderen voor iedereen een Standaard Boekhandel is binnen een straal van 7 km?

Vind hier een winkel

€ 10,95

+ 21 punten

Uitvoering

Levertermijn 1 à 4 weken

Eenvoudig bestellen

Veilig betalen

Gratis thuislevering vanaf € 30 (via bpost)

Gratis levering in je Standaard Boekhandel

Omschrijving

Unlock the economic layers of cancer immunotherapy with "Finance of Fighting Cancer: Costs, Access, Impact." This comprehensive guide delves into the financial dimensions of cancer treatment, focusing on the innovative yet costly realm of immunotherapy.Chapter 1, "Economic Overview of Cancer Immunotherapy," highlights cost analyses, funding mechanisms, and the broader economic impact on global healthcare systems, featuring poignant case studies that illustrate the personal financial challenges patients face when choosing immunotherapy.In Chapter 2, "The Cost of Checkpoint Inhibitors," we explore pricing for essential drugs and financial aid models aimed at making these treatments accessible. This chapter evaluates the long-term benefits versus the steep costs of these therapies.Chapter 3 examines "CAR T-Cell Therapy Expenses," detailing production costs, insurance hurdles, and their effects on patients and the healthcare economy. Chapter 4 covers the "Costs of Developing and Administering Cancer Vaccines," juxtaposing financial stakes with their revolutionary potential in preventive oncology.Chapters 5 through 11 navigate various immunotherapeutic approaches, including Oncolytic Virus Therapy and Bispecific Antibodies, discussing development costs, market adoption, and policies shaping availability.Concluding with Chapter 12, "Synthesizing Costs and Future Financial Strategies," the book proposes strategies to mitigate costs and enhance access to these life-saving treatments. Essential for healthcare finance professionals and policymakers, this book provides critical insights into the financial implications of adopting advanced cancer therapies.